Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

EBioMedicine(2022)10.1016/j.ebiom.2022.103972Source: DataRank Database

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals is a research paper published in EBioMedicine (2022). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 5.62)OA: goldTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Tamara García‐Salum ORCID,Catalina Pardo‐Roa ORCID,María José Avendaño ORCID,Eileen Serrano ORCID,Jorge Lévican

Live enrichment

PubMed:35366624 PMC:PMC8965458 OpenAlex:https://openalex.org/W4221042703

Comisión Nacional de Investigación Científica y Tecnológica

Grant: REDES180170

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00051

National Institute of Allergy and Infectious Diseases

Grant: 1U19AI135972

Agencia Nacional de Investigación y Desarrollo

Grant: 1161971

Agencia Nacional de Investigación y Desarrollo

Grant: FB210008

Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica

Grant: 1181799

JPB Foundation

Grant: 2020-215611 (5384

Fondo Nacional de Desarrollo Científico y Tecnológico

Grant: 1212023

National Institutes of Health

Grant: HHSN272201400008C

National Institutes of Health

Grant: 3190706

National Institutes of Health

Grant: 3190648

National Institutes of Health

Grant: R01AI132633

National Institute of Allergy and Infectious Diseases

Grant: U19AI135972

National Institutes of Health

Grant: 5U19AI135972-04

Fluomics: The Next Generation

National Institutes of Health

Grant: 5R01AI132633-04

Dissecting the receptor-mediated infection mechanisms of hantaviruses

Pontificia Universidad Católica de Chile

BHP

FWCI

5.62

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2352396422001566/pdf

publisherhttp://www.thelancet.com/article/S2352396422001566/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396422001566?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396422001566?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2022.103972

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches0303 health sciences03 medical and health sciencesAntibodies, NeutralizingAntibodies, ViralBNT162 VaccineCOVID-19COVID-19 VaccinesConvalescenceHumansSARS-CoV-2SARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineAntibodies, ViralConvalescenceHumansAntibodies, Neutralizing

Keywords

ConvalescenceMedicineVaccinationNeutralizing antibodyAntibodyCoronavirus disease 2019 (COVID-19)Antibody responsePandemicVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyDiseaseInternal medicineInfectious disease (medical specialty)Serological ResponseCovid-19Sars-cov-2 VaccinesNeutralizing Antibody PersistenceVaccination Boost570Medicine (General)COVID-19 VaccinesSARS-CoV-2R610ArticlesAntibodies, ViralAntibodies, NeutralizingR5-92003 Salud y bienestarHumans03 Good Health and Well-beingMedicina y saludBNT162 Vaccine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

FAIR Checklist

Authors (21)

Funding (17 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)